Posted on 10/1/20
PureTech Appoints Kiran Mazumdar-Shaw to Board
PureTech Health plc (LSE:PRTC), a clinical stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases
Posted on 10/1/20
Korro Bio Appoints Omar Khwaja, M.D., Ph.D. to Board
Korro Bio, Inc., a biotechnology company developing single-base RNA editing therapies, today announced the appointment of Omar Khwaja, M.D., Ph.D. to its board of directors.
Posted on 10/1/20
X4 Pharmaceuticals Appoints Alison Lawton To Board
X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway,
Posted on 10/1/20
AZTherapies Appoints Marc de Garidel Chief Executive Officer
AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the appointment of Marc de Garidel
Posted on 10/1/20
Kaleido Biosciences Appoints Daniel Menichella as CEO
Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health
Posted on 10/1/20
Sage Therapeutics Appoints Barry Greene to Board of Directors
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders
Posted on 10/1/20
Tarveda Therapeutics Appoints Brian Roberts as CEO
Tarveda Therapeutics, Inc., a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin
Posted on 9/30/20
Black Diamond Therapeutics Appoints Robert Ingram as Chairman
Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule
Posted on 9/29/20
Tertill Appoints Helen Greiner as CEO
Tertill Corporation today announced that Helen Greiner will take on the role of Chief Executive Officer and Chairman, effective immediately. Greiner will lead the Tertill Corporation
Posted on 9/29/20
Pulmatrix Appoints Todd Bazemore to Board
Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented
Posted on 9/29/20
Xilio Therapeutics Appoints Rachel Humphrey, M.D. to Board
Xilio Therapeutics, a company developing potent, tumor-selective immunotherapies for patients with cancer, today announced the appointment of Rachel Humphrey, M.D. as an independent member of the . . .
Posted on 9/29/20
Madaket Health Appoints Eric Demers as CEO
Madaket Health, a cloud-based platform that streamlines and simplifies administrative data exchange between healthcare payers and providers, today announced a transition
Posted on 9/29/20
Anokion Appoints Patricia Allen to Board
Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced the appointments of Patricia “Patty” Allen
Posted on 9/29/20
Michael Porter Joins the Board of Directors of ExThera Medical Corporation
Michael Porter, Ph.D., has joined the board of directors of ExThera Medical Corporation, a privately held medical technology company focused on the therapeutic reduction
Posted on 9/29/20
Alivio Therapeutics Appoints Harry Leider, M.D., to Board
Alivio Therapeutics, a biotechnology company developing an inflammation-targeting disease immunomodulation platform for the potential treatment of chronic and acute inflammatory disorders
Posted on 9/28/20
United Natural Foods CEO Steven Spinner to Retire
United Natural Foods, Inc. (NYSE: UNFI) today announced that Steven L. Spinner has informed the Board of Directors of his intention to
Posted on 9/28/20
Cognoptix Appoints Susanne Wilke CEO
Cognoptix, a healthcare company developing the Sapphire II System, a breakthrough technology for early detection of Alzheimer's disease (AD), announces the closing of an over-subscribed Series . . .
Posted on 9/28/20
HDT Global Appoints Jim Stephens as CEO
HDT Global, a leading provider of highly engineered solutions for extreme environments across military, public and private sector
Posted on 9/25/20
Frequency Therapeutics Appoints Cynthia Feldmann to Board
Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage
Posted on 9/25/20
Collegium Appoints Rita Balice-Gordon to Board
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the appointment of Rita Balice-Gordon to . . .
Posted on 9/25/20
Accent Therapeutics Appoints Julie Hambleton to Board
Accent Therapeutics, a biopharmaceutical company developing breakthrough treatments for cancer patients, announced today the appointment of Julie Hambleton, M.D., to its board of directors.
Posted on 9/24/20
Easterseals Capital Region & Eastern Connecticut Appoints Robin G. Sharp as CEO
Easterseals Capital Region & Eastern Connecticut's Board of Directors is pleased to announce the appointment of Ms. Robin G. Sharp to serve as the organization's new . . .
Posted on 9/24/20
Atomyze Appoints Jeanine Hightower-Sellitto as Chief Executive Officer
Atomyze, LLC, the US arm of a global fintech platform that will digitize and modernize trading markets for products, assets and commodities today announced the appointment . . .
Posted on 9/23/20
Cambridge Semantics Appoints Brian Owen as CEO
Cambridge Semantics, the leading provider of modern, graph-driven data integration for the enterprise data fabric, today announces
Posted on 9/23/20
Newmine Appoints Guy Hipwell To Advisory Board
Newmine, an innovative retail technology and consulting company, announced today the appointment of Guy Hipwell to their Advisory Board. Newmine expanded their reach into Europe in . . .
Boston
